Figure 1From: 5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosisPCA allows to distinguish NSCLC from NAT. Ten cases of adenocarcinomas (AdenoCa) and nine NAT matching samples, and eleven cases of SCC and seven NAT matching samples were hybridized to Affymetrix HGU133Plus2.0 arrays. All NSCLC samples (indicated in shades of red) clustered separately from the NAT samples (indicated in shades of green).Back to article page